Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, dated April 4, 2025, serves as a notice to shareholders regarding the upcoming 2025 Annual General Meeting (AGM). Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). The filing does not contain financial results for a specific reporting period but rather announces corporate governance activities.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not include financial statements or performance metrics.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The document focuses solely on the scheduling and logistics of the AGM.
Guidance, Outlook, and Management Commentary
- AGM Details: The 2025 AGM will be held virtually on Wednesday, May 28, 2025, at 3:00 pm BST, broadcast from the Company's London offices.
- Shareholder Documents: The Notice of AGM, Form of Proxy, and AGM Voting Instruction Card have been made available to shareholders.
- Access: Documents are available on the Company's investor website and have been submitted to the UK National Storage Mechanism in compliance with UK Listing Rule 6.4.1R.
Key Facts for Investor Verification
- Verify the date and time of the virtual AGM: May 28, 2025, at 3:00 pm BST.
- Confirm access to the Notice of AGM and voting instructions via the official Haleon investor website.
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F or quarterly reports for financial performance.